Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Velan-Repertoire to Withdraw Director Nominations Due to Pending Sale of Radius Health By: Velan-Repertoire Group via Business Wire July 11, 2022 at 08:00 AM EDT Sale Announcement Follows Successful Velan-Repertoire Campaign Featuring Three World-Class Director Candidates Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collectively one of the largest stockholders of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), with beneficial ownership of approximately 7.7% of the outstanding shares and economic exposure to approximately 10.1% of the outstanding shares, today released the following statement: “While we believe that the proposed sale to Gurnet Point Capital and Patient Square Capital does not reflect the full price of the Company and its assets, we are pleased that our involvement drove an outcome that ultimately should allow stockholders to recoup a portion of the value that has been lost under Radius’ current Board of Directors. As a result, we are withdrawing our director nominations. We are grateful to our exceptionally qualified director candidates Eric Ende, Cynthia Flowers, and Ann MacDougall for their time, expertise, and dedication to improving the Radius Board of Directors. We would also like to thank the fellow stockholders who supported us and our nominees both privately and publicly.” View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005407/en/Contacts Investors: Adam Morgan (646) 844-0030 campaign@velancapital.com Okapi Partners LLC Pat McHugh / Jason Alexander (212) 297-0720 info@okapipartners.com Media: Longacre Square Partners Dan Zacchei / Miller Winston DZacchei@longacresquare.com / MWinston@longacresquare.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Velan-Repertoire to Withdraw Director Nominations Due to Pending Sale of Radius Health By: Velan-Repertoire Group via Business Wire July 11, 2022 at 08:00 AM EDT Sale Announcement Follows Successful Velan-Repertoire Campaign Featuring Three World-Class Director Candidates Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collectively one of the largest stockholders of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), with beneficial ownership of approximately 7.7% of the outstanding shares and economic exposure to approximately 10.1% of the outstanding shares, today released the following statement: “While we believe that the proposed sale to Gurnet Point Capital and Patient Square Capital does not reflect the full price of the Company and its assets, we are pleased that our involvement drove an outcome that ultimately should allow stockholders to recoup a portion of the value that has been lost under Radius’ current Board of Directors. As a result, we are withdrawing our director nominations. We are grateful to our exceptionally qualified director candidates Eric Ende, Cynthia Flowers, and Ann MacDougall for their time, expertise, and dedication to improving the Radius Board of Directors. We would also like to thank the fellow stockholders who supported us and our nominees both privately and publicly.” View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005407/en/Contacts Investors: Adam Morgan (646) 844-0030 campaign@velancapital.com Okapi Partners LLC Pat McHugh / Jason Alexander (212) 297-0720 info@okapipartners.com Media: Longacre Square Partners Dan Zacchei / Miller Winston DZacchei@longacresquare.com / MWinston@longacresquare.com
Sale Announcement Follows Successful Velan-Repertoire Campaign Featuring Three World-Class Director Candidates
Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collectively one of the largest stockholders of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), with beneficial ownership of approximately 7.7% of the outstanding shares and economic exposure to approximately 10.1% of the outstanding shares, today released the following statement: “While we believe that the proposed sale to Gurnet Point Capital and Patient Square Capital does not reflect the full price of the Company and its assets, we are pleased that our involvement drove an outcome that ultimately should allow stockholders to recoup a portion of the value that has been lost under Radius’ current Board of Directors. As a result, we are withdrawing our director nominations. We are grateful to our exceptionally qualified director candidates Eric Ende, Cynthia Flowers, and Ann MacDougall for their time, expertise, and dedication to improving the Radius Board of Directors. We would also like to thank the fellow stockholders who supported us and our nominees both privately and publicly.” View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005407/en/
Investors: Adam Morgan (646) 844-0030 campaign@velancapital.com Okapi Partners LLC Pat McHugh / Jason Alexander (212) 297-0720 info@okapipartners.com Media: Longacre Square Partners Dan Zacchei / Miller Winston DZacchei@longacresquare.com / MWinston@longacresquare.com